Search Results

Myfembree for fibroid-associated heavy menstrual bleeding.

Subjects: Estradiol/Estradiol/Estradiol/*therapeutic use ; Leiomyoma/Leiomyoma/Leiomyoma/*complications ; Menorrhagia/Menorrhagia/Menorrhagia/*drug therapy

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Aug 09; Vol. 63 (1630), pp. 121-123.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium:

Record details

Norethisterone.

Subjects: Norethindrone/Norethindrone/Norethindrone/*adverse effects; Animals ; Carcinogenicity Tests

• Source: Report on carcinogens : carcinogen profiles [Rep Carcinog] 2004; Vol. 11, pp. III208-9.Publisher: National Institute of Environmental Health Sciences, [2000- Country of Publication: United States NLM ID: 101157309

Record details

Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.

• Authors : Hampton RM; Texas Tech University School of Medicine, Odessa, Texas, USA.; Fisher AC

Subjects: Practice Guidelines as Topic*; Contraception/Contraception/Contraception/*standards ; Ethinyl Estradiol/Ethinyl Estradiol/Ethinyl Estradiol/*adverse effects

• Source: Fertility and sterility [Fertil Steril] 2009 Aug; Vol. 92 (2), pp. 434-40. Date of Electronic Publication: 2008 Oct 18.Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772

Record details

Progestin-only contraceptive pill use among women in the United States.

• Authors : Hall KS; Office of Population Research, Princeton University, Princeton, NJ 08544, USA. ; Trussell J

Subjects: Contraception Behavior*; Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/*administration & dosage ; Progesterone Congeners/Progesterone Congeners/Progesterone Congeners/*administration & dosage

• Source: Contraception [Contraception] 2012 Dec; Vol. 86 (6), pp. 653-8. Date of Electronic Publication: 2012 Jun 06.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium:

Record details

Norgestrel, increased lipids: fact or "marketing monster"?

Subjects: Arteriosclerosis* ; Contraceptive Agents, Female* ; Contraceptives, Oral*

• Source: Contraceptive technology update [Contracept Technol Update] 1989 Oct; Vol. 10 (10), pp. 133-8.Publisher: American Health Consultants Country of Publication: United States NLM ID: 8214749 Publication Model: Print Cited

Record details

ON 7/7/7 is first choice for 60% of CTU survey respondents.

Subjects: Commerce* ; Community Health Workers* ; Contraception*

• Source: Contraceptive technology update [Contracept Technol Update] 1987 Sep; Vol. 8 (9), pp. 109-12.Publisher: American Health Consultants Country of Publication: United States NLM ID: 8214749 Publication Model: Print Cited

Record details

Three triphasic oral contraceptives now available in U.S.

Subjects: Contraception* ; Contraceptive Agents, Female* ; Contraceptives, Oral*

• Source: Contraceptive technology update [Contracept Technol Update] 1985 Jan; Vol. 6 (1), pp. 1-2, 4.Publisher: American Health Consultants Country of Publication: United States NLM ID: 8214749 Publication Model: Print Cited

Record details

Types of combined oral contraceptives used by US women.

• Authors : Hall KS; Office of Population Research, Princeton University, Princeton, NJ 08544, USA. ; Trussell J

Subjects: Contraception Behavior*; Contraceptives, Oral, Combined/Contraceptives, Oral, Combined/Contraceptives, Oral, Combined/*administration & dosage ; Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/*administration & dosage

• Source: Contraception [Contraception] 2012 Dec; Vol. 86 (6), pp. 659-65. Date of Electronic Publication: 2012 Jul 06.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium:

Record details

Considerations for the use of progestin-only contraceptives.

• Authors : Freeman S; Nell Hodgson Woodruff School of Nursing at Emory University, Atlanta, Georgia 30322, USA. ; Shulman LP

Subjects: Contraceptive Agents, Female*/Contraceptive Agents, Female*/Contraceptive Agents, Female*/adverse effects ; Contraceptive Agents, Female*/Contraceptive Agents, Female*/Contraceptive Agents, Female*/supply & distribution ; Progesterone Congeners*/Progesterone Congeners*/Progesterone Congeners*/adverse effects

• Source: Journal of the American Academy of Nurse Practitioners [J Am Acad Nurse Pract] 2010 Feb; Vol. 22 (2), pp. 81-91.Publisher: Slack for the American Academy of Nurse Practitioners Country of Publication: United States NLM ID: 8916634 Publication

Record details

Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.

• Authors : Mainwaring R; Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City 84132, USA.; Hales HA

Subjects: Body Weight/Body Weight/Body Weight/*drug effects ; Contraceptive Agents, Female/Contraceptive Agents, Female/Contraceptive Agents, Female/*pharmacology ; Menstrual Cycle/Menstrual Cycle/Menstrual Cycle/*drug effects

• Source: Contraception [Contraception] 1995 Mar; Vol. 51 (3), pp. 149-53.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print Cited Medium: Print

Record details